Icometrix is a neurotechnology company developing software that applies artificial intelligence to the analysis of brain MRI scans. The company focuses on automated, quantitative assessment of brain anatomy and pathology to support diagnosis, monitoring, and treatment planning in neurology.

Its platform uses machine learning algorithms to segment brain structures and measure imaging biomarkers related to neurodegenerative and neurological conditions, such as multiple sclerosis and dementia. The software standardizes image interpretation, reduces variability, and integrates into existing radiology and clinical workflows.

Icometrix’s solutions are deployed in hospitals, imaging centers, and research settings, as well as in pharmaceutical clinical trials. The company positions its technology as a neuroimaging analytics infrastructure that supports both routine clinical care and large-scale research rather than a standalone imaging modality.